Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NLRP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
mRNA | HNRNPH3 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
mRNA | CDCA5 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-08 |
mRNA | TSR2 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-08 |
mRNA | CKAP5 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-08 |
mRNA | RP11-192H23.4 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | MNDA | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
mRNA | CEP97 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | CARD6 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |